Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer
MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer
MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer
Submitted by
admin
on October 3, 2011 - 10:39am
Source:
Yahoo
News Tags:
MedImmune
cancer immunotherapy
Pfizer
tremelimumab
AstraZeneca
CTLA-4 monoclonal antibody
Headline:
MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer
Do Not Allow Advertisers to Use My Personal information
